Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies Upendra P. HegdeBijay Mukherji Review Open access 11 May 2017 Pages: 1113 - 1121
MuPeXI: prediction of neo-epitopes from tumor sequencing data Anne-Mette BjerregaardMorten NielsenAron Charles Eklund Original Article 20 April 2017 Pages: 1123 - 1130
Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Kosuke KawaguchiEiji SuzukiMasakazu Toi Original Article 21 April 2017 Pages: 1131 - 1142
FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy Simona RomanoEster SimeoneMaria Fiammetta Romano Original Article 22 April 2017 Pages: 1143 - 1151
The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series Xizhi WenYa DingXiaoshi Zhang Original Article 25 April 2017 Pages: 1153 - 1162
HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia Sanne SamuelsA. Marijne HeerenGemma G. Kenter Original Article 27 April 2017 Pages: 1163 - 1173
KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma Nan ChenWenfeng FangLi Zhang Original Article Open access 27 April 2017 Pages: 1175 - 1187
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma Elisa MazzoniSilvia PietrobonMauro Tognon Original Article 28 April 2017 Pages: 1189 - 1198
Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma Thilo GambichlerMartha GnielkaLutz Schmitz Original Article 13 May 2017 Pages: 1199 - 1204
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner Daniel W. FowlerJohn CopierMark D. Bodman-Smith Original Article Open access 13 May 2017 Pages: 1205 - 1215
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma Roger Gilabert-OriolSebastian G. B. FurnessPeter J. Wookey Original Article 13 May 2017 Pages: 1217 - 1228
Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model Lei ZhangLimin WangChuanlai Shen Original Article 13 May 2017 Pages: 1229 - 1241
Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2–4, 2016 Dolores Gallardo-RincónJuan Pablo MarquezEsteban Celis Meeting Report 08 May 2017 Pages: 1243 - 1247